Brief: Oncocyte Corp Reports Quarterly Earnings Per Share Of $0.02
May 11 (Reuters) - Oncocyte Corp OCX.O :
* ONCOCYTE REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
* QTRLY EARNINGS PER SHARE $0.02
* Q1 EARNINGS PER SHARE VIEW $-0.08 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbM4DBw
Further company coverage: OCX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission